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Bisphosphonate-induced osteonecrosis has been related to the cytotoxicity of these 
drugs on oral mucosa cells. A previous study showed that 5 µM of zoledronic acid (ZA), a 
nitrogen-containing bisphosphonate, is the highest concentration of this drug found in 
the oral cavity of patients under treatment. Therefore, in order to simulate an osteonecrosis 
clinical condition, the aim of this study was to evaluate the highest concentration of 
ZA applied on human epithelial cells (HaCaT) and gingival fibroblasts. For this purpose, 
cells (3x104 cells/cm²) were seeded in wells for 48 h using complete culture medium 
(cDMEM). After 48 h incubation, the cDMEM was replaced by fresh serum-free culture 
medium (DMEM-FBS) in which the cells were maintained for additional 24 h. Then, 5 µM 
ZA were added to the DMEM–FBS and the cells incubated in contact with the drug for 
48 h. After this period, the number of viable cells (trypan blue), cell viability (MTT assay), 
total protein (TP) production and cell morphology (SEM analysis) were assessed. Data were 
analyzed statistically by Mann-Whitney, ANOVA and Tukey’s test (α=0.05). ZA caused a 
significant reduction in the number of viable cells and decreased the metabolic activity 
of both cell lines. However, decrease of TP production occurred only in the epithelial cell 
cultures. Morphological alterations were observed in both cell types treated with ZA. In 
conclusion, ZA (5 µM) was cytotoxic to human epithelial cells and gingival fibroblast 
cultures, which could be associated, clinically, with the development of bisphosphonate-
induced osteonecrosis. 
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Bisphosphonates are a class of synthetic analogs 
of pyrophosphate, which have been widely used for 
treatment of different diseases characterized by intense 
bone resorption, such as Paget’s disease, osteoporosis, 
multiple myeloma, bone metastases of breast and prostate 
tumors (1-3). These drugs inhibit bone resorption mainly 
by inhibiting osteoclast differentiation and activity (4).
Nitrogen-containing bisphosphonates are more potent 
than non-nitrogenous bisphosphonates because their 
greater affinity for hydroxyapatite increases their adhesion 
to mineralized tissues (5). Recently, bisphosphonate therapy 
has been associated with the development of osteonecrosis 
in the oral cavity (5-7).
Bisphosphonate-induced osteonecrosis is characterized 
by exposed bone in the oral cavity, which persists for 6 to 
8 weeks without healing in patients who have been or are 
currently under bisphosphonate therapy and have no history 
of radiation therapy to the jaws (6). The etiopathogenesis 
of this condition has been related with several factors such 
as type of bisphosphonate, dose, treatment duration, and 
presence of associated local trauma, bacterial biofilms and 
local infections (6,7).
Some authors have recently hypothesized that the 
development of osteonecrosis induced by bisphosphonate 
could be related to a cytotoxic effect of this drug to oral 
mucosa cells (8-10). Zoledronic acid (ZA) is a highly potent 
nitrogen-containing bisphosphonate with a high capacity 
to adhere to the hydroxyapatite of mineralized dental 
tissues, and therefore has frequently been associated with 
the development of osteonecrosis (5,11,12). 
Because of the occlusal forces during the process of 
mastication, bone tissue of the jaws is under constant 
remodeling (12). In addition, traumas and local infections 
are also frequent in the jaws and periodontal disease is 
one of the main causes of bone resorption (13). Therefore, 
all these factors, alone or in combination, could promote 
the release of bisphosphonates during bone resorption and 
remodeling processes (6). The local release of large amounts 
of bisphosphonates may cause toxic effects to the oral 
mucosa cells adjacent to the bone tissue, resulting in loss 
of bone tissue lining (12). Other factors could also act, like 
biofilm formation on bone tissue (14), perpetuating bone 
exposure in the oral cavity (6).
Considering that little is known about the negative 
effects of bisphosphonates on cells of the mucosal lining 
of the oral cavity, the aim of this study was to evaluate in 
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vitro the potential toxic effects of ZA on epithelial cells 
and gingival fibroblast cultures.
Material and Methods
Cell Culture 
All experiments were performed using cultures of 
human epithelial cells (HaCaT-CLS 300493) and gingival 
fibroblasts (continuous cell line; Ethics Committee 
64/99-Piracicaba Dental School, UNICAMP, Brazil). The 
cells were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM; Sigma-Aldrich, St. Louis, MO, USA) supplemented 
with 10% fetal bovine serum (FBS; Gibco, Grand Island, NY, 
USA), with 100 IU/mL penicillin, 100 µg/mL streptomycin 
and 2 mM/L glutamine (Gibco) and maintained in a 
humidified incubator with 5% CO2 and 95% air at 37 °C 
(Isotemp; Fisher Scientific, Pittsburgh, PA, USA) Epithelial 
cells and gingival fibroblasts (3x104 cells/cm²) were seeded 
on sterile 24-well acrylic plates (Costar Corp., Cambridge, 
MA, USA) using plain DMEM supplemented with 10% FBS 
for 48 h. Thereafter, the culture medium was replaced by 
serum-free plain DMEM. 
ZA on Epithelial Cells and Gingival Fibroblast Cell 
Cultures
After the 24 h of culture in serum-free DMEM, 5µM 
ZA (Zometa® 4 mg; Novartis Biociências S.A., São Paulo, 
SP, Brazil) were added to the culture medium. This 
concentration was chosen based on a study by Scheper 
et al. (10), who reported that 5 µM was the highest ZA 
concentration (range from 0.7 to 4.6 mM) found in alveolar 
bone samples and saliva of patients under treatment with 
this drug. The culture medium with the drug remained in 
contact with the cells in the incubator with 5% CO2 and 
95% air at 37 °C for 48 h, after which time the cytotoxic 
effects of ZA were evaluated as described below. 
Viable Cell Counting (Trypan Blue Assay)
Trypan blue assay was used to evaluate the number of 
viable cells in the culture after ZA treatment. This test is 
based on the fact that the trypan blue dye can penetrate 
only permeable membranes of lethally damaged (dead) 
cells, changing their color into blue, which is detectable 
under optical microscopy (15,16). After 48 h of treatment, 
cell counting was evaluated in experimental and control 
groups for each cell line. For that, cells were detached using 
0.25% trypsin (Invitrogen, Carlsbad, CA, USA), for 10 min. 
Then 50 µL aliquots of this cell suspension were added to 
50 µL of 0.04% trypan blue dye (Sigma Aldrich) and the 
resulting solution was maintained at room temperature for 
2 min. Next, the cells were counted with an automated cell 
counter (TC10 Automated Cell Counter 145-0001; Bio-Rad 
Laboratories, Inc., Hercules, CA, USA). For each sample, the 
cell counter provided the total number of cells, the number 
of viable cells and their percentages. 
Analysis of Cell Viability (MTT Assay)
Cell viability was evaluated using the methyltetrazolium 
(MTT) assay (17-19). This test determines the activity of 
SDH enzyme, which is a measure of cellular (mitochondrial) 
respiration, and can be considered as the metabolic rate 
of cells. After 48 h of incubation of the cells in contact 
with DMEM alone (control group) or containing ZA at 
5 μM concentration (experimental group), the culture 
medium was aspirated and replaced by 900 μL of fresh 
DMEM plus 100 μL of MTT solution (Sigma-Aldrich) (5 
mg/mL sterile PBS). The cells in contact with the MTT 
solution were incubated at 37 °C for 4 h. Thereafter, the 
culture medium with the MTT solution was aspirated and 
replaced by 700 μL of acidified isopropanol solution (0.04 
N HCl) in each well to dissolve the violet formazan crystals 
producing a homogenous bluish solution resulting from the 
cleavage of the MTT salt ring by the SDH enzyme present 
in the mitochondria of viable cells. After agitation and 
confirmation of the homogeneity of the solutions, three 
100 μL aliquots of each well were transferred to a 96-well 
plate (Costar Corp., Cambridge, MA, USA). Cell viability was 
evaluated by spectrophotometry as being proportional 
to the absorbance measured at 570 nm wavelength with 
an ELISA plate reader (Thermo Plate, Nanshan District, 
Shenzhen, Guangdong, China). The values obtained from 
the three aliquots were averaged to provide a single value. 
The absorbance was expressed in numerical values, which 
were subjected to statistical analysis to determine the effect 
of ZA on the viability of the cells. A sample of each group 
was selected to obtain images of MTT salt impregnation 
in the cells after the test (Figs. 1 and 2).
Total Protein (TP) Production
TP production was evaluated according to the Read 
and Northcote (20) protocol, as previously described by 
Oliveira et al. (21). After 48-h incubation of the cells in 
contact with DMEM alone (control group) or containing 
ZA (experimental group), the culture medium was aspirated 
and 1 mL of 0.1% sodium lauryl sulphate (Sigma Aldrich) 
was added to each well and maintained for 40 min at room 
temperature to produce cell lysis, followed by the addition 
of 1 mL of Lowry reagent solution (Sigma Aldrich). After 
20 min at room temperature, 500 µL of Folin-Ciocalteau’s 
phenol reagent solution (Sigma Aldrich) were added to 
each sample and homogenized. Thirty minutes later, three 
100 µL aliquots of each tube were transferred to a 96-well 
plate and the absorbance of the test was measured at 655 
nm wavelength with the ELISA plate reader (Thermo Plate). 
Total protein production was calculated from a standard 

















curve created using known protein concentrations.
Analysis of Cell Morphology by Scanning Electron 
Microscopy (SEM)
SEM analysis was used to identify possible morphological 
alterations caused by ZA on epithelial cell and gingival 
fibroblast cell cultures. The following protocol used in 
previous studies was employed (17,19). Sterile 13-mm-
diameter cover glasses (Fisher Scientific) were placed on 
the bottom of the wells immediately before seeding the 
cells. After 48 h of incubation in contact with DMEM alone 
(control group) or containing ZA (experimental group), the 
culture medium was aspirated and the cells were fixed in 1 
mL of 2.5% glutaraldehyde (Sigma-Aldrich) in PBS for 1 h at 
room temperature. Then, the glutaraldehyde was aspirated 
and the cells were washed with PBS and post-fixed with 
1% osmium tetroxide (Electron Microscopy Science, Fort 
Washington, PA, USA) for 1 h at room temperature. The cells 
that remained adhered to the glass substrate were washed 
again with PBS and distilled water for two consecutive times 
for 5 and 15 min respectively, and then dehydrated in a 
series of increasing ethanol concentrations (30, 50 and 70%, 
one time for 30 min each; 95 and 100%, two times for 60 
min each). The cells were immersed for 60 min (three 20-
min changes) in 200 µL of 1,1,1,3,3,3-hexamethyldisilazane 
(HMDS; ACROS Organics, New Jersey, NY, USA). Finally, the 
cells were mounted on metallic stubs, stored in a desiccator 
for 24 h and sputter-coated with a 20-nm gold-palladium 
layer (SDC 050; Bal-Tec AG, Balzers, Germany), and their 
morphology was examined with a scanning electron 
microscope (JEOL USA Inc., Peabody, MA, USA). 
Statistical Analysis
For the epithelial cell culture, after assessing the 
distribution (Shapiro-Wilk, p>0.05) and homogeneity of 
variances (Levene, p>0.05) (SPSS), the viable cell number 
(trypan blue assay), cell viability (SDH production) and 
TP production data were analyzed by the nonparametric 
Mann-Whitney test.
For the gingival fibroblast cell cultures, after analysis 
of distribution (Shapiro-Wilk, p>0.05) and homogeneity 
of variances (Levene, p>0.05), the viable cell number 
(trypan blue assay), cell viability (SDH production) and TP 
production data were independently subjected to one-way 
analysis of variance (treatment: control x 5 µM ZA). As 
the null hypothesis of absence of differences among the 
groups was rejected, additional Tukey’s tests were applied. 
A significance level of 5% was set for all analyses.
Figure 1. Number of viable cells in the human gingival fibroblasts and 
epithelial cell cultures, with and without zoledronic acid treatment 
(G1-control group; G2-ZA 5 µM).
Figure 2. Photomicrographs of human epithelial cells (HaCaT) under light inverted microscopy (TS100; Nikon Corp, Tokyo, Japan). A: In control group, 
a large number of elongated cells near to confluence covering the surface of the glass substrate are observed. B: When the cells were exposed to ZA, 
an intense reduction in the number of viable cells, leaving wide cell-free glass substrate zones, can be seen. Original magnification 10×.











After the incubation period with DMEM containing 
ZA, both cell lines presented a significant reduction in 
the number of viable cells compared to the control group 
(p<0.05) (Fig. 1).
The application of ZA reduced significantly the viability 
(SDH production) of epithelial cells (Table 1 and Fig. 2) and 
gingival fibroblasts (Table 2 and Fig. 3) compared to the 
control group (p<0.05). 
 The contact of 5µM ZA with the epithelial cells for 48 
h also reduced significantly TP production compared to the 
control group (p<0.05) (Table 1). However, for the gingival 
fibroblasts, no statistically significant difference occurred 
between the treated and control groups (p>0.05) (Table 2).
The morphological analysis of epithelial cells and 
gingival fibroblasts by SEM after treatment with 5 µM 
ZA showed that the drug promoted severe morphological 
alterations in both cell types. In the treated groups, the 
cells exhibited a shrunken cytoplasm and a number of cells 
detached from the glass substrate, leaving wide cell-free 
zones (Figs. 4 and 5).
Discussion
The effects of bisphosphonates on different cell types 
have been extensively investigated. However, only a few 
studies have evaluated the effects of a bisphosphonate 
on two cell types using the same dose and incubation 
time (9,12,22).
The present study evaluated the effect of ZA, a 
highly potent nitrogen-containing bisphosphonate, on 
epithelial cells and gingival fibroblasts with the main goal 
of determining whether the drug concentration (5 µM) 
found in the alveolar bone tissue of patients subjected 
to ZA therapy (10) could have toxic effects to cultures of 
these cell lines. 
The results of the present investigation are relevant 
because of the high incidence of bisphosphonate-induced 
osteonecrosis and due to the fact that the etiopathogenesis 
and treatment protocols for this kind of disease have not 
been completely elucidated. Therefore, knowledge of the 
etiopathogenesis of this condition is very important to 
prevent and treat osteonecrosis lesions improving the 
Figure 3. Photomicrographs of human gingival fibroblasts under light inverted microscope (TS100; Nikon). A: In control group, there are a number of 
cells near to the confluence covering the surface of glass substrate. B: In the group treated with zoledronic acid, a significant reduction in the number 
of viable cells occurred. The cells adhered to the substrate exhibit a round shape. Original magnification 10×.
Table 1. Data of cell viability (percentage values) and total protein 
production (percentage values) of human epithelial cell (HaCaT) cultures 
incubated with zoledronic acid
Groups Cell viability (%)
Total protein 
production (%)
Control 100 (96.1-104.04) A 100 (93.28-121.82) A
Zoledronic acid 33.28 (17.09-51.27) B 65.31 (59.71-77.64) B
All values are given as medians (percentile 25-percentile 75).
In each column, groups identified with different letters are statistically 
different (Mann-Whitney, p<0.05).
Table 2. Data of cell viability (percentage values) and total protein 
production (percentage values) of human gingival fibroblast cell cultures 
exposed to zoledronic acid
Groups Cell viability (%) Total protein production
Control 100 (20.17)A 100 (31.83) A
Zoledronic acid 60.52 (16.66) B 106.83 (30.27) A
All values are given as mean (standard deviation), n=12, for both products 
of cell metabolism. Means followed by same letters in columns do not 
differ significantly (Tukey’s test, p>0.05).

















patients’ quality of life. 
Concerning the methodology employed, epithelial 
cells and gingival fibroblasts were used, since these cell 
populations play an active role on oral mucosa homeostasis 
and tissue healing (23). In addition, the interaction between 
epithelial cells and fibroblasts is directly related to the oral 
mucosa repair (23). However, in spite of the interesting data 
presented in previous studies (10,24), only few researchers 
compared the toxicity of bisphosphonates on epithelial 
cells and fibroblasts (9,10). This kind of laboratory test 
is relevant since the toxic effect of bisphosphonates, 
especially ZA on oral mucosa cells, is the main cause of 
osteonecrosis development and its maintenance. It should 
also be reported that the specific ZA concentration used 
in the present investigation represents the amount of ZA 
found in saliva and bone of patients under ZA treatment 
(10). All these facts together could justify the development 
of the present in vitro study, which definitively contributes 
to the research field.
Overall, the results showed that ZA reduced significantly 
the number of viable cells of both cell lines and decreased 
the viability of epithelial cells and fibroblasts by 70% and 
40%, respectively. Previous studies demonstrated, in the 
same way as observed in the present investigation, the 
sensitivity of human epithelial cells and fibroblasts to 
treatment with ZA. Scheper et al. (9) evaluated the effects of 
ZA (0.25 to 3 µM) on epithelial cells and fibroblast cultures 
and observed a similar effect for both cell types, with a 
significant decrease of cell proliferation at concentrations 
above 1 µM. In a subsequent study, the same authors 
confirmed their previous findings and also demonstrated a 
significant increase in the apoptotic ratio in the epithelial 
cells after treatment with ZA at concentrations above 1 µM 
(10). In a recent study, Ravosa et al. (24) found a greater 
sensitivity of the epithelial cells to the cytotoxicity of 
ZA, with a significant decrease in cell viability after 48-h 
Figure 4. SEM micrographs showing the morphology of normal epithelial cells (A/B - control group) and ZA-treated epithelial cells (C/D - experimental 
group). A: The cells exhibit discrete fusiform morphology near to confluence on the substrate. SEM, Original magnification 200×. B: High magnification 
of the Figure 4A. Note that the cells close to confluence present slightly elongated morphology. SEM, Original magnification 500×. C: A number of 
epithelial cells with shrunken cytoplasm compared to the control group can be observed on the glass substrate. SEM, Original magnification 200×. 
D: Detail of ‘C’. Fragments of dead cells that detached from the substrate can be seen among epithelial cells with cytoplasm shrinkage. SEM, Original 
magnification 500×. 










Figure 5. SEM micrographs showing the morphology of normal gingival fibroblasts (A/B - control group) and ZA-treated fibroblasts (C/D - experimental 
group). A: Numerous fibroblasts with discrete fusiform morphology adhered to the substrate are observed. Original magnification 200×. B: Detail of ‘A’ 
showing fibroblasts with a wide cytoplasm. Original magnification 500×. C: Although several fibroblasts remained adhered to the substrate, numerous 
flake structures can be observed. Original magnification 200×. D: High magnification of ‘C’, in which round-shaped cells with disrupted cytoplasmic 
membrane among rests of dead fibroblast that detached from the glass substrate can be seen. Original magnification 500×.
incubation with the drug at concentrations higher than 10 
µM. For gingival fibroblasts, on the other hand, the same 
effect was observed only for concentrations above 30 µM. 
The divergence of results in these studies may be due to 
the use of different concentrations of the drug, contact 
times and cell lines. 
In the present study, a significant decrease in TP 
production by the epithelial cells was observed, suggesting 
that bisphosphonates can reduce protein production of 
this cell type and may have a negative effect on the repair 
and healing of oral tissues. The same result, however, was 
not observed for the gingival fibroblasts treated with ZA, 
which confirms that different cell lines can have different 
responses to the drug.
Agis et al. (25) evaluated the effect of ZA (30 µM) on 
gingival fibroblast cultures and also found a significant 
decrease of cell viability and proliferation. However, they 
found a decrease of TP production by the fibroblasts, which 
differ from the findings of the present study. These divergent 
results may be related to the higher ZA concentrations 
used by those authors, as a dose-dependent cytotoxicity 
of bisphosphonates on different cell cultures has been 
demonstrated (9,12,24). On the other hand, Walter et 
al. (12) found an 80% decrease of viability (MTT assay) 
of fibroblasts incubated with 5 µM ZA for 24 h, while in 
the present study, a 48-h incubation time caused a 40% 
decrease in gingival fibroblast viability. These results suggest 
that the cytotoxicity of the ZA is not time-dependent. 
In the same way as in the present study, Scheper 
et al. (9) evaluated the effect of ZA on the death and 
proliferation of epithelial cells and fibroblasts, but using 
lower concentrations of the drug. The authors found that 
ZA produced a dose-dependent increase in apoptotic ratios 
in both cell lines and observed a significant decrease of cell 
proliferation only for concentrations higher than 1 µM.
The analysis of cell morphology by SEM revealed 
the occurrence of death with consequent detachment 
from the glass substrate of some epithelial cells and 

















fibroblasts treated with ZA. In addition, most cells that 
remained adhered to the substrate presented remarkable 
morphological alterations. These results confirm that the 
concentration used in the present study (5 µM) caused 
cytotoxic effects to the epithelial cell and gingival fibroblast 
cultures, confirming the results of the MTT assay used to 
evaluate the viability of both cell lines after the treatment. 
The etiopathogenesis of bisphosphonates-induced 
osteonecrosis has not yet been elucidated. However, knowing 
that the alveolar bone is constantly remodeling (12,13), 
bisphosphonates that adhere to the bone of patients under 
ZA therapy can be released from mineralized tissues during 
the bone formation and resorption processes. Therefore, the 
accumulation of bisphosphonates at high concentrations 
in the tissues may have toxic effects to the cells in this 
microenvironment, such as fibroblasts, endothelial cells, 
osteoblasts and epithelial cells (8,12). In the present in vitro 
study, the concentration of ZA detected in the bone tissue 
of patients subjected to bisphosphonate therapy (5 µM) 
(10) caused cytotoxic effects to epithelial cell and gingival 
fibroblast cell cultures in vitro. However, these preliminary 
results cannot be extrapolated to the clinical situations 
until further research is done. Other studies are necessary 
to investigate the effects of bisphosphonates on the oral 
microenvironment to understand the etiopathogenesis of 
bisphosphonate-induced osteonecrosis and, in the future, 
prevent the occurrence of this condition or at least use 
more effective therapies with less severe side effects. 
Under the conditions of this study, it may be concluded 
that ZA (5 µM) causes toxic effects to cultures of human 
epithelial cells and gingival fibroblasts, which could be 
associated with the occurrence of bisphosphonate-induced 
osteonecrosis in patients under therapy with this drug.
Resumo 
A osteonecrose induzida por bisfosfonatos tem sido associada a um 
efeito citotóxico destes medicamentos sobre as células da mucosa 
oral. Um estudo recente demonstrou que 5 µM de ácido zoledrônico 
(AZ), um potente bisfosfonato nitrogenado, foi a maior concentração 
encontrada na cavidade oral da pacientes em tratamento com este 
medicamento. Portanto, para simular esta condição in vivo, o objetivo 
deste estudo foi avaliar o efeito da aplicação desta concentração de 
AZ sobre células epiteliais (HaCaT) e fibroblasto de gengiva. As células 
foram semeadas (3x104 células/cm²) e incubadas por 48 h em placas de 
24 compartimentos, utilizando meio de cultura completo (cDMEM). Após 
permanecer por 24 h em DMEM sem soro fetal bovino (DMEM-SFB), 5 
µM do AZ foram adicionados a este meio de cultura, o qual foi incubado 
em contato com as células por 48 h. Após este período, foram avaliados 
o número de células viáveis (trypan blue), viabilidade celular (teste de 
MTT), produção de proteína total e a morfologia celular (MEV). Os dados 
obtidos foram submetidos aos testes estatísticos de Mann-Whitney e 
ANOVA complementada por testes de Tukey (p>0,05). Foi demonstrado 
que o AZ causou diminuição significativa no número de células viáveis, 
além de redução do metabolismo celular para ambos os tipos celulares 
avaliados. Porém, redução na produção de proteína total ocorreu apenas 
para as células epiteliais. Alterações morfológicas foram observadas em 
ambos os tipos celulares tratados com AZ. Estes dados científicos indicam 
que a concentração de AZ avaliada neste estudo (5  mM) apresenta ação 
citotóxica sobre células epiteliais e fibroblastos de gengiva, o que poderia 
estar associado, clinicamente, ao desenvolvimento da osteonecrose 
induzida por bisfosfonatos.
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